Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality

ConclusionIn hypogonadal men with a modest prevalence of established CVD, TRT was not observed to confer a protective or adverse effect on the risk of MI, CVA or all-cause mortality.

Source: Basic and Clinical Andrology - March 28, 2019 Category: Urology & Nephrology Source Type: research